Protection of cortical cells by equine estrogens against glutamate-induced excitotoxicity is mediated through a calcium independent mechanism

BMC Neuroscience

Volumn 6, Issue , 2005, Pages

  Perrella, Joel ^a,b   Bhavnani, Bhagu R ^a,b  

^a UNIVERSITY OF TORONTO   (Canada)

^b ST MICHAEL'S HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIOXIDANT; CALCIUM ION; DELTA8 ESTRADIOL; DIZOCILPINE; ESTRADIOL; ESTRADIOL DERIVATIVE; FREE RADICAL; GLUTAMIC ACID; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; N(G) NITROARGININE METHYL ESTER; NEUROPROTECTIVE AGENT; NITRIC OXIDE SYNTHASE; PEROXYNITRITE; UNCLASSIFIED DRUG; AMINO ACID RECEPTOR STIMULATING AGENT; CALCIUM; ESTROGEN;

ALZHEIMER DISEASE; ANIMAL CELL; ARTICLE; BRAIN CORTEX; CALCIUM CELL LEVEL; CALCIUM TRANSPORT; CELL VIABILITY; CONCENTRATION RESPONSE; CONTROLLED STUDY; DEGENERATIVE DISEASE; DRUG MECHANISM; ENZYME INHIBITION; ESTROGEN THERAPY; EXCITOTOXICITY; NERVE CELL CULTURE; NERVE CELL NECROSIS; NEUROPROTECTION; NEUROTOXICITY; NONHUMAN; PATHOGENESIS; POSTMENOPAUSE; RAT; ANIMAL; CELL CULTURE; CELL SURVIVAL; COMPARATIVE STUDY; DOSE RESPONSE; DRUG EFFECT; FEMALE; HORSE; METABOLISM; PHYSIOLOGY; PREGNANCY; SPRAGUE DAWLEY RAT;

ANIMALS; CALCIUM; CELL SURVIVAL; CELLS, CULTURED; CEREBRAL CORTEX; DOSE-RESPONSE RELATIONSHIP, DRUG; ESTROGENS; EXCITATORY AMINO ACID AGONISTS; FEMALE; GLUTAMIC ACID; HORSES; NEUROPROTECTIVE AGENTS; PREGNANCY; RATS; RATS, SPRAGUE-DAWLEY;

EID: 26444486039     PISSN: 14712202     EISSN: 14712202     Source Type: Journal    
DOI: 10.1186/1471-2202-6-34     Document Type: Article

References (53)

1. Choi DW: Glutamate neurotoxicity and diseases of the nervous system. Neuron 1988, 1(8):623-34.
2. Lipton SA, Rosenberg PA: Excitatory amino acids as a final common pathway for neurologic disorders. N Engl J Med 1994, 330(9):613-22.
3. Coyle JT, Puttfarcken P: Oxidative stress, glutamate, and neurodegenerative disorders. Science 1993, 262(5134):689-95.
4. Olney JW, Wozniak DF, Farber NB: Glumate receptor dysfunction and Alzheimer's disease. Restor Neurol Neurosci 1998, 13(1-2) :75-83.
5. Ankarcrona M, Dypbukt JM, Bonfoco E, Zhivotovsky B, Orrenius S, Lipton SA, Nicotera P: Glutamate-induced neuronal death: a succession of necrosis or apoptosis depending on mitochondrial function. Neuron 1995, 15(4):961-73.
6. Choi DW: Excitotoxic cell death. J Neurobiol 1992, 23(9):1261-76.
7. Murphy TH, Miyamoto M, Sastre A, Schnaar RL, Coyle JT: Glutamate toxicity in a neuronal cell line involves inhibition of cystine transport leading to oxidative stress. Neuron 1989, 2(6):1547-58.
8. Li Y, Maher P, Schubert D: Phosphatidylcholine-specific phospholipase C regulates glutamate-induced nerve cell death. Proc Natl Acad Sci U S A 1998, 95(13):7748-53.
9. Sattler R, Tymianski M: Molecular mechanisms of calcium-dependent excitotoxicity. J Mol Med 2000, 78(1):3-13.
10. Siegel GJ, Agranoff BW, Albers RW, Fisher SK, Uhler MD: Basic Neurochemistry: molecular, cellular and medical aspects. 6th edition. Lippincott Williams and Wilkins, American Society for Neurochemistry; 1999.
11. Yamauchi M, Omote K, Ninomiya T: Direct evidence for the role of nitric oxide on the glutamate-induced neuronal death in cultured cortical neurons. Brain Res 1998, 780(2):253-9.
12. Dawson VL, Dawson TM, London ED, Bredt DS, Snyder SH: Nitric oxide mediates glutamate neurotoxicity in primary cortical cultures. Proc Natl Acad Sci U S A 1991, 88(14):6368-71.
13. Bhavnani BR, Berco M, Binkley J: Equine estrogens differentially prevent neuronal cell death induced by glutamate. J Soc Gynecol Investig 2003, 10(5):302-8.
14. Zhang YM, Lu XF, Bhavnani BR: Equine estrogens differentially inhibit DNA fragmentation induced by glutamate in neuronal cells by modulation of regulatory proteins involved in programmed cell death. BMC Neurosci 2003, 4(1):32.
15. Brinton RD, Chen S, Montoya M, Hsieh D, Minaya J: The estrogen replacement therapy of the Women's Health Initiative promotes the cellular mechanisms of memory and neuronal survival in neurons vulnerable to Alzheimer's disease. Maturitas 2000, 34(Suppl 2):S35-52.
16. Brinton RD, Proffitt P, Tran J, Luu R: Equilin, a principal component of the estrogen replacement therapy premarin, increases the growth of cortical neurons via an NMDA receptor-dependent mechanism. Exp Neurol 1997, 147(2):211-20.
17. Paganini-Hill A, Henderson VW: Estrogen deficiency and risk of Alzheimer's disease in women. Am J Epidemiol 1994, 140(3):256-61.
18. Henderson VW: The epidemiology of estrogen replacement therapy and Alzheimer's disease. Neurology 1997, 48(5 Suppl 7):S27-35.
19. Tang MX, Jacobs D, Stern Y, Marder K, Schofield P, Gurland B, Andrews H, Mayeux R: Effect of oestrogen during menopause on risk and age at onset of Alzheimer's disease. Lancet 1996, 348(9025):429-32.
20. Kawas C, Resnick S, Morrison A, Brookmeyer R, Corrada M, Zonderman A, Bacal C, Lingle DD, Metter E: A prospective study of estrogen replacement therapy and the risk of developing Alzheimer's disease: the Baltimore Longitudinal Study of Aging. Neurology 1997, 48(6):1517-21.
21. Perrella J, Berco M, Cecutti A, Gerulath A, Bhavnani BR: Potential role of the interaction between equine estrogens, low-density lipoprotein (LDL) and high-density lipoprotein (HDL) in the prevention of coronary heart and neurodegenerative diseases in postmenopausal women. Lipids Health Dis 2003, 2(1):4.
22. Bhavnani BR, Cecutti A, Gerulath A, Woolever AC, Berco M: Comparison of the antioxidant effects of equine estrogens, red wine components, vitamin E, and probucol on low-density lipoprotein oxidation in postmenopausal women. Menopause 2001, 8(6):408-19.
23. Singer CA, Rogers KL, Strickland TM, Dorsa DM: Estrogen protects primary cortical neurons from glutamate toxicity. Neurosci Lett 1996, 212(1):13-6.
24. Nilsen J, Chen S, Brinton RD: Dual action of estrogen on glutamate-induced calcium signaling: mechanisms requiring interaction between estrogen receptors and src/mitogen activated protein kinase pathway. Brain Res 2002, 930(1-2) :216-34.
25. Nilsen J, Diaz Brinton R: Mechanism of estrogen-mediated neuroprotection: regulation of mitochondrial calcium and Bcl-2 expression. Proc Natl Acad Sci U S A 2003, 100(5):2842-7.
26. 8-estrone in postmenopausal women and men. J Steroid Biochem Mol Biol 1998, 67(2):119-31.
27. Bhavnani BR, Lu XF: Differential interaction of equine estrogens with recombinant human estrogen receptors alpha (ERα) and beta (ERβ) [abstract]. J Soc Gynecol Investig 2003, 10(suppl):298A.
28. Fryer HJL, Knox RJ, Strittmatter SM, Kalb RG: Excitotoxic death of a subset of embryonic rat motor neurons in vitro. J Neurochem 1999, 72(2):500-13.
29. 2+ dependent. Neuroreport 1995, 6(6):945-8.
30. Carriedo SG, Yin HZ, Weiss JH: Motor neurons are selectively vulnerable to AMPA/Kainate receptor-mediated injury in vitro. J Neurosci 1996, 16(13):4069-79.
31. Bonfoco E, Krainc D, Ankarcrona M, Nicotera P, Lipton SA: Apoptosis and necrosis: two distinct events induced, respectively, by mild and intense insults with N-methyl-D-aspartate or nitric oxide/superoxide in cortical cell cultures. Proc Natl Acad Sci USA 1995, 92(16):7162-6.
32. Samdani AF, Newcamp C, Resink A, Facchinetti F, Hoffman BE, Dawson VL, Dawson TM: Differential susceptibility to neurotoxicity mediated by neurotrophins and neuronal nitric oxide synthase. J Neurosci 1997, 17(12):4633-41.
33. Brewer GJ, Torricelli JR, Evege EK, Price PJ: Optimized survival of hippocampal neurons in B27-supplemented Neurobasal, a new serum-free medium combination. J Neurosci Res 1993, 35(5):567-76.
34. Brewer GJ: Serum-free B27/neurobasal medium supports differentiated growth of neurons from the striatum, substantia nigra, septum, cerebral cortex, cerebellum, and dentate gyrus. J Neurosci Res 1995, 42(5):674-83.
35. Schubert D, Piasecki D: Oxidative glutamate toxicity can be a component of the excitotoxicity cascade. J Neurosci 2001, 21(19):7455-62.
36. Regan RF, Choi DW: Glutamate neurotoxicity in spinal cord cell culture. Neuroscience 1991, 43(2-3):585-91.
37. Zhang Y, Bhavnani BR: Equine estrogens inhibit glutamateinduced neuronal apoptosis by caspase-3 dependent and independent mechanisms involving mitochondrial release of cytochrome c (Cyto C) and apoptosis inducing factor (AIF) [abstract]. J Soc Gynecol Investig 2004, 11(2 suppl):240.
38. Mattson MP: Excitotoxic and excitoprotective mechanisms: abundant targets for the prevention and treatment of neurodegenerative disorders. Neuromolecular Med 2003, 3(2):65-94.
39. Lok J, Martin LJ: Rapid subcellular redistribution of Bax precedes caspase-3 and endonuclease activation during excitotoxic neuronal apoptosis in rat brain. J Neurotrauma 2002, 19(7):815-28.
40. Brecht S, Gelderblom M, Srinivasan A, Mielke K, Dityateva G, Herdegen T: Caspase-3 activation and DNA fragmentation in primary hippocampal neurons following glutamate excitotoxicity. Brain Res Mol Brain Res 2001, 94(1-2):25-34.
41. Bhavnani BR, Nisker JA, Martin J, Aletebi F, Watson L, Milne JK: Comparison of pharmacokinetics of a conjugated equine estrogen preparation (premarin) and a synthetic mixture of estrogens (C.E.S.) in postmenopausal women. J Soc Gynecol Investig 2000, 7(3):175-83.
42. Berco M, Bhavnani BR: Differential neuroprotective effects of equine estrogens against oxidized low density lipoproteininduced neuronal cell death. J Soc Gynecol Investig 2001, 8(4):245-54.
43. Shui-Pang T, Bhavnani BR: Differential effects of various equine estrogens mediated via estrogen receptor α and β in HepG2 cells [abstract]. The Endocrine Society, 85th Annual Meeting 2003, P1-104:12.
44. Levin ER: Cellular functions of plasma membrane estrogen receptors. Steroids 2002, 67(6):471-5.
45. 2+ accumulation in cortical cell culture correlates with subsequent neural degeneration. J Neurosci 1993, 13(5):1993-2000.
46. Murphy AN, Bredesen DE, Cortopassi G, Wang E, Fiskum G: Bcl-2 potentiates the maximal calcium uptake capacity of neural cell mitochondria. Proc Natl Acad Sci U S A 1996, 93(18):9893-8.
47. Ichimiya M, Chang SH, Liu H, Berezesky IK, Trump BF, Amstad PA: Effect of Bcl-2 on oxidant-induced cell death and intracellular Ca2+ mobilization. Am J Physiol 1998, 275(3 Pt 1):C832-9.
48. Lee SY, Andoh T, Murphy DL, Chiueh CC: 17β-estradiol activates ICI 182,780-sensitive estrogen receptors and cyclic GMPdependent thioredoxin expression for neuroprotection. FASEB J 2003, 17(8):947-8.
49. Scordalakes EM, Shetty SJ, Rissman EF: Roles of estrogen receptor alpha and androgen receptor in the regulation of neuronal nitric oxide synthase. J Comp Neurol 2002, 453(4):336-44.
50. Singer CA, Figueroa-Masot XA, Batchelor RH, Dorsa DM: The mitogen-activated protein kinase pathway mediates estrogen neuroprotection after glutamate toxicity in primary cortical neurons. J Neurosci 1999, 19(7):2455-63.
51. Singh M, Meyer EM, Simpkins JW: The effect of ovariectomy and estradiol replacement on brain-derived neurotrophic factor messenger ribonucleic acid expression in cortical and hippocampal brain regions of female Sprague-Dawley rats. Endocrinology 1995, 136(5):2320-4.
52. Panickar KS, Guan G, King MA, Rajakumar G, Simpkins JW: 17β-estradiol attenuates CREB decline in the rat hippocampus following seizure. J Neurobiol 1997, 33(7):961-7.
53. Willis D, Tomlinson A, Frederick R, Paul-Clark MJ, Willoughby DA: Modulation of heme oxygenase activity in rat brain and spleen by inhibitors and donors of nitric oxide. Biochem Biophys Res Commun 1995, 214(3):1152-6.